Medical Science Liaison (MSL)

In pharmaceutical sales, the sales representatives push on the gas pedal while the regulatory affairs members push on the brake pedal. The result is that sales organizations are often slow moving, dangerous and subject to frequent break downs. Medical Science Liaisons (MSLs), if they have enough judgment, training, and participation, can articulate the company’s sales objectives and the regulatory limits, and in doing so can help the company determine the speed it wants to go, and which pedal needs pushing.

CIS realizes that, in reality, the issues are not as simple as faster or slower. In fact, there are multiple, complex factors involved...

  • multiple ways to communicate product benefits to practitioners and consumers;
  • multiple media and message combinations;
  • multiple ways of assessing the protocols of the available research; and
  • multiple ways of interpreting the results of the studies.

CIS helps organizations address these factors and achieve their goals by developing sophisticated programs that are tailored to the organizational structure, products, research base, and sales culture of the organization. Some additional compliance areas that CIS supports are:

  • Policies for Phase IV Studies
  • Protected Health Information Activities
  • Closer Adherence to the Personal Services Safe Harbor
  • Information Technology